Vanguard Personalized Indexing Management
DGX icon

Vanguard Personalized Indexing Management’s Quest Diagnostics DGX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7M Buy
17,463
+257
+1% +$50.4K 0.03% 430
2026
Q1 		$3.37M Buy
17,206
+645
+4% +$125K 0.03% 431
2025
Q4 		$2.87M Sell
16,561
-136
-0.8% -$24.8K 0.03% 474
2025
Q3 		$3.18M Buy
16,697
+748
+5% +$133K 0.03% 423
2025
Q2 		$2.87M Buy
15,949
+3,785
+31% +$657K 0.03% 454
2025
Q1 		$2.06M Buy
12,164
+697
+6% +$115K 0.03% 487
2024
Q4 		$1.73M Buy
11,467
+821
+8% +$128K 0.03% 525
2024
Q3 		$1.65M Buy
10,646
+1,065
+11% +$159K 0.03% 540
2024
Q2 		$1.31M Buy
9,581
+2,265
+31% +$310K 0.02% 566
2024
Q1 		$974K Buy
7,316
+196
+3% +$25.4K 0.02% 673
2023
Q4 		$982K Sell
7,120
-906
-11% -$119K 0.03% 658
2023
Q3 		$978K Sell
8,026
-556
-6% -$74.1K 0.03% 566
2023
Q2 		$1.21M Buy
8,582
+1,848
+27% +$255K 0.04% 481
2023
Q1 		$953K Buy
6,734
+647
+11% +$92.6K 0.03% 558
2022
Q4 		$952K Sell
6,087
-7,881
-56% -$1.13M 0.04% 528
2022
Q3 		$1.71M Buy
13,968
+7,665
+122% +$1.01M 0.08% 263
2022
Q2 		$838K Buy
6,303
+750
+14% +$102K 0.04% 554
2022
Q1 		$760K Buy
5,553
+79
+1% +$11K 0.04% 613
2021
Q4 		$947K Buy
5,474
+725
+15% +$110K 0.06% 421
2021
Q3 		$690K Buy
4,749
+882
+23% +$129K 0.06% 359
2021
Q2 		$510K Buy
3,867
+1,209
+45% +$158K 0.05% 469
2021
Q1 		$341K Buy
2,658
+48
+2% +$5.92K 0.05% 453
2020
Q4 		$311K Buy
2,610
+19
+0.7% +$2.32K 0.07% 360
2020
Q3 		$297K Buy
+2,591
New +$306K 0.08% 290

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Vanguard Personalized Indexing Management's DGX Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Quest Diagnostics (DGX) stake by 1.5% in Q2 2026, buying an estimated $50.4K and bringing the position to 17,463 shares worth $3.7M. The position accounts for 0.03% of the portfolio, ranked #430.

Vanguard Personalized Indexing Management first reported a position in DGX in Q3 2020 and has held it in 24 quarters since. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Vanguard Personalized Indexing Management held 17,463 shares of Quest Diagnostics worth $3.7M as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 257 Quest Diagnostics shares in Q2 2026, an estimated $50.4K.
  • Quest Diagnostics made up 0.03% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #430 holding.
  • Vanguard Personalized Indexing Management first reported a position in Quest Diagnostics in Q3 2020 and has held it in 24 quarters since.
  • 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.